Industry Strength Score
11/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
SEMLER SCIENTIFIC INC (SMLR) Stock Price & Overview
NASDAQ:SMLR • US81684M1045
Current stock price
20.33 USD
-1.04 (-4.87%)
At close:
20.33 USD
0 (0%)
After Hours:
The current stock price of SMLR is 20.33 USD. Today SMLR is down by -4.87%. In the past month the price increased by 16.84%. In the past year, price decreased by -68.57%.
SMLR Key Statistics
52-Week Range14.885 - 65.98
Current SMLR stock price positioned within its 52-week range.
1-Month Range14.885 - 24.1884
Current SMLR stock price positioned within its 1-month range.
- Market Cap
- 308.203M
- P/E
- 2.32
- Fwd P/E
- 249.14
- EPS (TTM)
- 8.76
- Dividend Yield
- N/A
SMLR Stock Performance
Today
-4.87%
1 Week
-1.64%
1 Month
+16.84%
3 Months
-12.30%
Longer-term
6 Months -50.70%
1 Year -68.57%
2 Years -54.10%
3 Years -48.15%
5 Years N/A
10 Years N/A
SMLR Stock Chart
SMLR Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to SMLR. When comparing the yearly performance of all stocks, SMLR is a bad performer in the overall market: 92.43% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
SMLR Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to SMLR. While SMLR is still in line with the averages on profitability rating, there are concerns on its financial health.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
SMLR Earnings
On November 12, 2025 SMLR reported an EPS of 1.07 and a revenue of 7.49M. The company beat EPS expectations (1998.04% surprise) and missed revenue expectations (-6.63% surprise).
Next Earnings DateFeb 16, 2026
Last Earnings DateNov 12, 2025
PeriodQ3 / 2025
EPS Reported$1.07
Revenue Reported7.491M
EPS Surprise 1,998.04%
Revenue Surprise -6.63%
SMLR Forecast & Estimates
9 analysts have analysed SMLR and the average price target is 66.98 USD. This implies a price increase of 229.46% is expected in the next year compared to the current price of 20.33.
For the next year, analysts expect an EPS growth of -95.59% and a revenue growth -43.2% for SMLR
Analysts
Analysts82.22
Price Target66.98 (229.46%)
EPS Next Y-95.59%
Revenue Next Year-43.2%
SMLR Index Membership
SMLR is currently included in the following stock indexes tracked on ChartMill.
SMLR Financial Highlights
Over the last trailing twelve months SMLR reported a non-GAAP Earnings per Share(EPS) of 8.76. The EPS increased by 220.88% compared to the year before.
Income Statements
Revenue(TTM)36.96M
Net Income(TTM)48.34M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 130.8% | ||
| ROA | 8.1% | ||
| ROE | 10.51% | ||
| Debt/Equity | 0.25 |
Chartmill High Growth Momentum
EPS Q2Q%48.61%
Sales Q2Q%-44.56%
EPS 1Y (TTM)220.88%
Revenue 1Y (TTM)-37.3%
SMLR Ownership
Ownership
Inst Owners65.81%
Shares15.16M
Float13.36M
Ins Owners4.75%
Short Float %N/A
Short RatioN/A
SMLR Industry Overview
SMLR operates in the Health Care Equipment sub-industry within the Health Care sector. This group contains 127 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
60/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
22%
Outperformed 22% of sub-industries
3 Month Rank
14%
Outperformed 14% of sub-industries
6 Month Rank
11%
Outperformed 11% of sub-industries
Industry Fundamentals & Breadth
- Members
- 127
- New Highs
- 2.4%
- New Lows
- 14.2%
- Average ROE
- 17.2%
- Average Profit Margin
- 20.3%
- Average Operating Margin
- 22.5%
- Average P/E
- 28.1
- Average Fwd P/E
- 27.3
- Average Debt/Equity
- 0.5
SMLR Competitors/Peers
The largest stocks on the US markets in the "Health Care Equipment" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 39.25 | 162.529B | ||
| ABT | ABBOTT LABORATORIES | 14.24 | 157.763B | ||
| SYK | STRYKER CORP | 17.41 | 120.688B | ||
| BSX | BOSTON SCIENTIFIC CORP | 14.31 | 85.619B | ||
| EW | EDWARDS LIFESCIENCES CORP | 24.9 | 48.141B | ||
| IDXX | IDEXX LABORATORIES INC | 38.32 | 44.539B | ||
| BDX | BECTON DICKINSON AND CO | 10.94 | 42.438B | ||
| RMD | RESMED INC | 16.7 | 31.148B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 10.74 | 27.761B | ||
| DXCM | DEXCOM INC | 20.18 | 22.918B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 9.11 | 15.956B | ||
| PEN | PENUMBRA INC | 63.83 | 12.837B | ||
| GMED | GLOBUS MEDICAL INC - A | 20.03 | 12.197B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About SMLR
Company Profile
Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. The company is headquartered in Campbell, California and currently employs 79 full-time employees. The company went IPO on 2014-02-27. The firm's flagship product, QuantaFlo, which is patented and cleared by the United States Food and Drug Administration (FDA), is a rapid point-of-care test that measures arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of cardiovascular diseases, such as peripheral arterial disease (PAD), and the Company is seeking a new 510(k) clearance for expanded-indications. QuantaFlo is used by healthcare providers to evaluate their patient's risk of mortality and major adverse cardiovascular events (MACE). QuantaFlo features a sensor clamp that is placed on the toe or finger. A blood flow waveform is instantaneously constructed by its software algorithm. The firm delivers QuantaFlo directly to its customers. The firm also invests in bitcoin and has adopted Bitcoin as its primary treasury asset.
Company Info
IPO: 2014-02-27
SEMLER SCIENTIFIC INC
51 E Campbell Ave, Suite 107-D
Campbell CALIFORNIA 97210 US
CEO: Douglas Murphy-Chutorian
Employees: 79
Phone: 18777744211
SEMLER SCIENTIFIC INC / SMLR FAQ
What does SEMLER SCIENTIFIC INC do?
Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. The company is headquartered in Campbell, California and currently employs 79 full-time employees. The company went IPO on 2014-02-27. The firm's flagship product, QuantaFlo, which is patented and cleared by the United States Food and Drug Administration (FDA), is a rapid point-of-care test that measures arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of cardiovascular diseases, such as peripheral arterial disease (PAD), and the Company is seeking a new 510(k) clearance for expanded-indications. QuantaFlo is used by healthcare providers to evaluate their patient's risk of mortality and major adverse cardiovascular events (MACE). QuantaFlo features a sensor clamp that is placed on the toe or finger. A blood flow waveform is instantaneously constructed by its software algorithm. The firm delivers QuantaFlo directly to its customers. The firm also invests in bitcoin and has adopted Bitcoin as its primary treasury asset.
What is the stock price of SEMLER SCIENTIFIC INC today?
The current stock price of SMLR is 20.33 USD. The price decreased by -4.87% in the last trading session.
What is the dividend status of SEMLER SCIENTIFIC INC?
SMLR does not pay a dividend.
What is the ChartMill rating of SEMLER SCIENTIFIC INC stock?
SMLR has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Is SEMLER SCIENTIFIC INC (SMLR) expected to grow?
The Revenue of SEMLER SCIENTIFIC INC (SMLR) is expected to decline by -43.2% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is SEMLER SCIENTIFIC INC worth?
SEMLER SCIENTIFIC INC (SMLR) has a market capitalization of 308.20M USD. This makes SMLR a Small Cap stock.
What is the next earnings date for SMLR stock?
SEMLER SCIENTIFIC INC (SMLR) will report earnings on 2026-02-16.